Literature DB >> 8833279

Adapting cognitive behavioral therapy for the frail elderly.

R W Grant1, D A Casey.   

Abstract

Depression is a common psychiatric disorder of the aged. This article briefly reviews the literature on the use of cognitive behavioral therapy (CBT) with the elderly, and suggests some changes in using CBT with the elderly based on the authors' clinical experiences. Recommended changes in technique and common themes when dealing with the frail elderly are described, including the use of "supportive CBT" for patients with mild cognitive impairment. The authors' experiences suggest that CBT is an effective treatment for depression and other affective disorders of the frail elderly, and is especially useful when somatic treatments are contraindicated or produce intolerable side effects.

Entities:  

Mesh:

Year:  1995        PMID: 8833279     DOI: 10.1017/s1041610295002298

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  4 in total

1.  [Acute illness and depression in the elderly and the influence of cognitive impairment : AIDE-cog trial].

Authors:  J Hummel; C Weisbrod; L Bösch; K Himpler; G Böhm; S Diener; A Gaebel; L Dipper; T Zieschang; P Oster; D Kopf
Journal:  Z Gerontol Geriatr       Date:  2012-01-27       Impact factor: 1.281

Review 2.  Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

Authors:  Vasiliki Orgeta; Phuong Leung; Rafael Del-Pino-Casado; Afifa Qazi; Martin Orrell; Aimee E Spector; Abigail M Methley
Journal:  Cochrane Database Syst Rev       Date:  2022-04-25

Review 3.  Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

Authors:  Vasiliki Orgeta; Afifa Qazi; Aimee E Spector; Martin Orrell
Journal:  Cochrane Database Syst Rev       Date:  2014-01-22

4.  Adapting cognitive behaviour therapy for tele-psychotherapy services for COVID-19.

Authors:  Jaiganesh Selvapandiyan
Journal:  Psychiatry Res       Date:  2022-02-25       Impact factor: 11.225

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.